After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Dyne Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Dyne Therapeutics Inc is $1.28B. A total of 1.8 million shares were traded on the day, compared to an average of 2.25M shares.
In the most recent transaction, Friedl-Naderer Johanna sold 143 shares of DYN for 12.12 per share on Mar 13 ’25. After the transaction, the Chief Commercial Officer now owns 96,057 company shares. In a previous transaction on Mar 11 ’25, Scalzo Richard William sold 1,343 shares at 11.38 per share. DYN shares that SVP, Head of Finance & Admin. owns now total 122,330.
Among the insiders who sold shares, Beskrovnaya Oxana disposed of 2,153 shares on Mar 11 ’25 at a per-share price of $11.38. This resulted in the Chief Scientific Officer holding 195,840 shares of DYN after the transaction. In another insider transaction, Beskrovnaya Oxana bought 2,153 shares at $11.38 per share on Mar 11 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, DYN has a high of $47.45 and a low of $6.36.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. DYN’s latest balance sheet shows that the firm has $376.57M in Cash & Short Term Investments as of fiscal 2021. There were $32.64M in debt and $28.72M in liabilities at the time. Its Book Value Per Share was $6.16, while its Total Shareholder’s Equity was $368.20M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DYN is Buy with a score of 4.79.
